S&P 500   3,117.07 (-0.10%)
DOW   27,861.86 (-0.26%)
QQQ   203.28 (-0.04%)
CGC   17.13 (+11.81%)
BABA   182.89 (-1.27%)
GE   11.40 (-0.96%)
T   36.99 (-2.68%)
ACB   2.58 (+10.26%)
F   8.77 (-1.46%)
BAC   32.62 (-0.97%)
DIS   148.16 (-0.15%)
S&P 500   3,117.07 (-0.10%)
DOW   27,861.86 (-0.26%)
QQQ   203.28 (-0.04%)
CGC   17.13 (+11.81%)
BABA   182.89 (-1.27%)
GE   11.40 (-0.96%)
T   36.99 (-2.68%)
ACB   2.58 (+10.26%)
F   8.77 (-1.46%)
BAC   32.62 (-0.97%)
DIS   148.16 (-0.15%)
S&P 500   3,117.07 (-0.10%)
DOW   27,861.86 (-0.26%)
QQQ   203.28 (-0.04%)
CGC   17.13 (+11.81%)
BABA   182.89 (-1.27%)
GE   11.40 (-0.96%)
T   36.99 (-2.68%)
ACB   2.58 (+10.26%)
F   8.77 (-1.46%)
BAC   32.62 (-0.97%)
DIS   148.16 (-0.15%)
S&P 500   3,117.07 (-0.10%)
DOW   27,861.86 (-0.26%)
QQQ   203.28 (-0.04%)
CGC   17.13 (+11.81%)
BABA   182.89 (-1.27%)
GE   11.40 (-0.96%)
T   36.99 (-2.68%)
ACB   2.58 (+10.26%)
F   8.77 (-1.46%)
BAC   32.62 (-0.97%)
DIS   148.16 (-0.15%)
Log in

West Pharmaceutical Services Stock Price, Forecast & Analysis (NYSE:WST)

$150.16
+0.44 (+0.29 %)
(As of 11/20/2019 10:48 AM ET)
Today's Range
$149.70
Now: $150.16
$150.51
50-Day Range
$137.28
MA: $143.61
$150.15
52-Week Range
$91.75
Now: $150.16
$152.10
Volume1,176 shs
Average Volume401,577 shs
Market Capitalization$11.11 billion
P/E Ratio53.44
Dividend Yield0.43%
Beta1.25
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. Read More…

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 billion
Cash Flow$4.27 per share
Book Value$18.85 per share

Profitability

Net Income$206.90 million

Miscellaneous

Employees7,700
Market Cap$11.11 billion
Next Earnings Date2/13/2020 (Estimated)
OptionableOptionable

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, July 25th. Investors of record on Wednesday, October 23rd will be given a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 annualized dividend and a yield of 0.40%. The ex-dividend date is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services declared that its board has initiated a stock buyback plan on Thursday, February 15th 2018, which permits the company to repurchase 800,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, October, 24th. The medical instruments supplier reported $0.79 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.71 by $0.08. The medical instruments supplier earned $456.10 million during the quarter, compared to the consensus estimate of $450.03 million. West Pharmaceutical Services had a net margin of 12.82% and a return on equity of 16.66%. The company's revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.76 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY19 earnings guidance on Thursday, October, 24th. The company provided EPS guidance of $3.10-3.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.06. The company issued revenue guidance of $1.815-1.825, compared to the consensus revenue estimate of $1.81 billion.

What price target have analysts set for WST?

3 Wall Street analysts have issued 1 year target prices for West Pharmaceutical Services' shares. Their forecasts range from $112.16 to $122.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $117.08 in the next year. This suggests that the stock has a possible downside of 22.0%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

Headlines about WST stock have been trending somewhat negative on Wednesday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. West Pharmaceutical Services earned a news impact score of -1.3 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for West Pharmaceutical Services.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 668,400 shares, an increase of 12.2% from the September 30th total of 595,700 shares. Based on an average daily trading volume, of 343,700 shares, the days-to-cover ratio is presently 1.9 days. Currently, 0.9% of the company's shares are sold short. View West Pharmaceutical Services' Current Options Chain.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Johnson & Johnson (JNJ), Lowe's Companies (LOW), Mcdonald's (MCD), Nike (NKE), Stanley Black & Decker (SWK), PepsiCo (PEP), Medtronic (MDT), AFLAC (AFL), NVIDIA (NVDA) and CVS Health (CVS).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (1.84%), Massachusetts Financial Services Co. MA (1.27%), Fisher Asset Management LLC (1.21%), Riverbridge Partners LLC (0.80%), USS Investment Management Ltd (0.72%) and GW&K Investment Management LLC (0.46%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including USS Investment Management Ltd, Eagle Asset Management Inc., AMI Asset Management Corp, Vaughan Nelson Investment Management L.P., Public Employees Retirement Association of Colorado, Massachusetts Financial Services Co. MA, Fisher Asset Management LLC and Oppenheimer & Co. Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, WCM Investment Management LLC, State of Tennessee Treasury Department, State of New Jersey Common Pension Fund D, Chicago Equity Partners LLC, California Public Employees Retirement System, Kistler Tiffany Companies LLC and Russell Investments Group Ltd.. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $150.16.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $11.11 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  551
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: FAANG Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel